Electrocardiography of Laboratory Animals
Autor: | Jeffrey W. Richig, Meg M. Sleeper |
---|---|
EAN: | 9780128097007 |
eBook Format: | |
Sprache: | Englisch |
Produktart: | eBook |
Veröffentlichungsdatum: | 02.11.2018 |
Kategorie: | |
Schlagworte: | Abnormalities Atrial tachycardia (AT)AV block Atrial tachycardia (AT)Bundle branch blocks (BBBs)Dogs Beagle Blood pressure (BP)High-Definition Oscillometry (HDO)Noninvasive Bundle branch blocks (BBBs)C Preclinical safety and safety pharmacology |
265,00 €*
Versandkostenfrei
Die Verfügbarkeit wird nach ihrer Bestellung bei uns geprüft.
Bücher sind in der Regel innerhalb von 1-2 Werktagen abholbereit.
Electrocardiography of Laboratory Animals, Second Edition, is the only publication covering electrocardiography of laboratory animals. With countries instituting requirements for the care of laboratory animals in research, this publication offers a standard on performing and analyzing ECGs. Topics covered include safety electrocardiography, toxicology, safety pharmacology, and telemetry, all important areas of discussion for biological and medical researchers, veterinarians, zoologists, and students who need to understand the electrocardiography of five species of animals used in research: canines, nonhuman primates, mini pigs, rodents (rats and mice), rabbits and cats. - Offers guidance in interpretation of laboratory animal ECGs by animal type - Provides comparisons of ECGs across animal species - Includes coverage of three animal species: canines, nonhuman primates and mini pigs, also including three additional species: rodents (rats and mice), rabbits and cats - Supports adherence to FDA requirements of ECG performance and qualitative analysis on large laboratory animals
Jeffrey W. Richig, DVM is CEO of ECGVET, LLC and Special Government Employee consultant to the FDA for the cardiovascular and renal drugs division. He has over twenty-five years of experience in electrocardiography for pre-clinical safety evaluation studies and is known as a leading expert in the field.
Jeffrey W. Richig, DVM is CEO of ECGVET, LLC and Special Government Employee consultant to the FDA for the cardiovascular and renal drugs division. He has over twenty-five years of experience in electrocardiography for pre-clinical safety evaluation studies and is known as a leading expert in the field.